journal
https://read.qxmd.com/read/38643351/synthesis-docking-study-and-antitumor-evaluation-of-benzamides-and-oxadiazole-derivatives-of-3-phenoxybenzoic-acid-as-vegfr-2-inhibitors
#1
JOURNAL ARTICLE
Mohammad H Heriz, Ammar A R Mahmood, Salem R Yasin, Khaled M Saleh, Mai F AlSakhen, Sana I Kanaan, Nisreen Himsawi, Abdulrahman M Saleh, Lubna H Tahtamouni
Current chemotherapeutic agents have several limitations, including lack of selectivity, the development of undesirable side effects, and chemoresistance. As a result, there is an unmet need for the development of novel small molecules with minimal side effects and the ability to specifically target tumor cells. A new series of 3-phenoxybenzoic acid derivatives, including 1,3,4-oxadiazole derivatives (4a-d) and benzamides derivatives (5a-e) were synthesized; their chemical structures were confirmed by Fourier-transform infrared spectroscopy, 1 H nuclear magnetic resonance (NMR), 13 C NMR, and mass spectra; and various physicochemical properties were determined...
May 2024: Drug Development Research
https://read.qxmd.com/read/38634273/in-vitro-and-in-silico-investigation-of-fda-approved-drugs-to-be-repurposed-against-alzheimer-s-disease
#2
JOURNAL ARTICLE
Didem Akkaya, Gökçe Seyhan, Suat Sari, Burak Barut
Alzheimer's disease (AD), one of the main causes of dementia, is a neurodegenerative disorder. Cholinesterase inhibitors are used in the treatment of AD, but prolonged use of these drugs can lead to serious side effects. Drug repurposing is an approach that aims to reveal the effectiveness of drugs in different diseases beyond their clinical uses. In this work, we investigated in vitro and in silico inhibitory effects of 11 different drugs on cholinesterases. The results showed that trimebutine, theophylline, and levamisole had the highest acetylcholinesterase inhibitory actions among the tested drugs, and these drugs inhibited by 68...
May 2024: Drug Development Research
https://read.qxmd.com/read/38628078/synthesis-and-investigation-of-the-cholinesterase-inhibitory-and-antioxidant-capacities-of-some-novel-n-quinolin-4-ylmethylene-propanehydrazides-against-alzheimer-s-disease
#3
JOURNAL ARTICLE
Burcu Kilic, Deniz S Dogruer
One of the worst long-term health issues of the past few decades is Alzheimer's disease (AD). Unfortunately, there are currently insufficient choices for treating and caring for AD, which makes it a popular subject for drug development research. Studies on the development of drugs for AD have primarily concentrated on the use of multitarget directed ligands. Following this strategy, we designed new ChE inhibitors with additional antioxidant and metal chelator effects. In this research, eight novel N'-(quinolin-4-ylmethylene)propanehydrazide derivatives were synthesized and characterized...
May 2024: Drug Development Research
https://read.qxmd.com/read/38619209/single-and-multiple-inhibitors-of-the-biosynthesis-of-5-12-15-lipoxygenase-products-derived-from-cinnamyl-3-4-dihydroxy-%C3%AE-cyanocinnamate-synthesis-and-structure-activity-relationship
#4
JOURNAL ARTICLE
Mohamed Touaibia, Audrey Isabel Chiasson, Samuel Robichaud, Jérémie A Doiron, Mathieu P A Hébert, Marc E Surette
The involvement of lipoxygenases in various pathologies, combined with the unavailability of safe and effective inhibitors of the biosynthesis of their products, is a source of inspiration for the development of new inhibitors. Based on a structural analysis of known inhibitors of lipoxygenase products biosynthesis, a comprehensive structure-activity study was carried out, which led to the discovery of several novel compounds (16a-c, 17a) demonstrating promising potency to inhibit the biosynthesis of products of 5-, 12- and 15-LO...
May 2024: Drug Development Research
https://read.qxmd.com/read/38616512/ythdf2-promotes-gastric-cancer-progression-and-enhances-chemoradiotherapy-resistance
#5
JOURNAL ARTICLE
Jian Yang, Yawen Chen, Yang He, Mingxu Da
The role of YTHDF2 in gastric cancer (GC) is controversial. Due to the limitations of technical difficulty and experimental period, research on completely knocking out YTHDF2 is rare. Therefore, further investigations are still needed to clarify the YTHDF2's clinical significance and biological function in GC. To carry out the investigation, an analysis was performed on the expression levels of YTHDF2 in both publicly available databases and samples obtained from patients with gastric cancer. Based on the complete knockout of YTHDF2 using the CRISPR-Cas9 system, in vivo and in vitro experiments were conducted to analyze the effects of YTHDF2 on tumor formation, radiotherapy and chemoradiotherapy resistance in GC...
April 2024: Drug Development Research
https://read.qxmd.com/read/38567708/new-insights-into-the-anticancer-therapeutic-potential-of-icaritin-and-its-synthetic-derivatives
#6
REVIEW
Octavio Daniel Reyes-Hernández, Gabriela Figueroa-González, Laura Itzel Quintas-Granados, Hector Hernández-Parra, Sheila I Peña-Corona, Hernán Cortés, Aliya Kipchakbayeva, Zhazira Mukazhanova, Solomon Habtemariam, Gerardo Leyva-Gómez, Dietrich Büsselberg, Javad Sharifi-Rad
Icaritin is a natural prenylated flavonoid derived from the Chinese herb Epimedium. The compound has shown antitumor effects in various cancers, especially hepatocellular carcinoma (HCC). Icaritin exerts its anticancer activity by modulating multiple signaling pathways, such as IL-6/JAK/STAT3, ER-α36, and NF-κB, affecting the tumor microenvironment and immune system. Several clinical trials have evaluated the safety and efficacy of icaritin in advanced HCC patients with poor prognoses, who are unsuitable for conventional therapies...
April 2024: Drug Development Research
https://read.qxmd.com/read/38528652/the-contribution-of-the-wnt-pathway-to-the-therapeutic-effects-of-montelukast-in-experimental-murine-airway-inflammation-induced-by-ovalbumin-and-lipopolysaccharide
#7
JOURNAL ARTICLE
Yesim Kaya-Yasar, Seckin Engin, Elif Nur Barut, Cihan Inan, Ismail Saygin, Ilknur Erkoseoglu, Sena F Sezen
The wingless/integrase-1 (WNT) pathway involved in the pathogenesis of inflammatory airway diseases has recently generated considerable research interest. Montelukast, a leukotriene receptor antagonist, provides therapeutic benefits in allergic asthma involving eosinophils. We aimed to investigate the role of the WNT pathway in the therapeutic actions of montelukast (MT) in a mixed type of allergic-acute airway inflammation model induced by ovalbumin (OVA) and lipopolysaccharide (LPS) in mice. Female mice were sensitized with intraperitoneal OVA-Al(OH)3 administration in the initiation phase and intranasal OVA followed by LPS administration in the challenge phase...
April 2024: Drug Development Research
https://read.qxmd.com/read/38528637/cellular-and-molecular-mechanisms-involved-in-the-analgesic-effects-of-botulinum-neurotoxin-a-literature-review
#8
REVIEW
Saereh Hosseindoost, Seyed Hassan Inanloo, Seyed Khalil Pestehei, Mojgan Rahimi, Reza Atef Yekta, Alireza Khajehnasiri, Maziyar Askari Rad, Hossein Majedi, Ahmad Reza Dehpour
Botulinum neurotoxins (BoNTs), derived from Clostridium botulinum, have been employed to treat a range of central and peripheral neurological disease. Some studies indicate that BoNT may be beneficial for pain conditions as well. It has been hypothesized that BoNTs may exert their analgesic effects by preventing the release of pain-related neurotransmitters and neuroinflammatory agents from sensory nerve endings, suppressing glial activation, and inhibiting the transmission of pain-related receptors to the neuronal cell membrane...
April 2024: Drug Development Research
https://read.qxmd.com/read/38515272/pyridazine-and-pyridazinone-derivatives-synthesis-and-in-vitro-investigation-of-their-anti-inflammatory-potential-in-lps-induced-raw264-7-macrophages
#9
JOURNAL ARTICLE
Eman O Osman, Nadia A Khalil, Alaa Magdy, Yara El-Dash
New pyridazine and pyridazinone derivatives 3a-g, 4a-f, 6a, and 6b were designed and synthesized. Cell viability of all compounds was established based on the viability of lipopolysaccharide-induced RAW264.7 macrophage cells determined via the MTT assay. In vitro inhibition assays on human COX-1 and COX-2 enzymes were conducted to probe the newly synthesized compounds' anti-inflammatory activity. The half maximal inhibitory concentration values for the most active compounds, 3d, 3e, and 4e towards COX-2 were 0...
April 2024: Drug Development Research
https://read.qxmd.com/read/38494997/investigation-of-apoptotic-effects-of-cucurbitacin-d-i-and-e-mediated-by-bax-bcl-xl-caspase-3-9-and-oxidative-stress-modulators-in-hepg2-cell-line
#10
JOURNAL ARTICLE
Muhammed Mehdi Üremiş, Yusuf Türköz, Nuray Üremiş
Cucurbitacins, natural compounds highly abundant in the Cucurbitaceae plant family, are characterized by their anticancer, anti-inflammatory, and hepatoprotective properties. These compounds have potential as therapeutic agents in the treatment of liver cancer. This study investigated the association of cucurbitacin D, I, and E (CuD, CuI, and CuE) with the caspase cascade, Bcl-2 family, and oxidative stress modulators in the HepG2 cell line. We evaluated the antiproliferative effects of CuD, CuI, and CuE using the MTT assay...
April 2024: Drug Development Research
https://read.qxmd.com/read/38488434/improving-therapeutic-potential-in-breast-cancer-via-histone-deacetylase-inhibitor-loaded-nanofibrils
#11
JOURNAL ARTICLE
Praveetha Senthilkumar, Bhaskar Gogoi, Swati Smita Dhan, Ramesh Subramani, Charumathi Pushparaj, Ayyavu Mahesh
Epigenetic modifications play a significant role in cancer progression, making them potential targets for therapy. Histone deacetylase inhibitors have shown promise in inhibiting cancer cell growth, including in breast cancer (BC). In this research, we examined the potential of using suberoyl anilide hydroxamic acid (SAHA)-loaded β-lg nanofibrils as a drug delivery system for triple-negative BC cell lines. We assessed their impact on cell cycle progression, apoptosis, levels of reactive oxygen species, and mitochondrial membrane potential in cancer cells...
April 2024: Drug Development Research
https://read.qxmd.com/read/38481011/xanthones-with-multiple-roles-against-diabetes-their-synthesis-structure-activity-relationship-and-mechanism-studies
#12
JOURNAL ARTICLE
Youhong Ke, Qinfang Xu, Jianling Hu, Jianrun Zhang, Shijian Chen, Zhijun Liu, Shuling Peng, Chao Zhang, Zhenqiang Chen, Heru Chen
A four-step synthetic process has been developed to prepare 1,3,5,8-tetrahydroxyxanthone (2a) and its isomer 1,3,7,8-tetrahydroxyxanthone (2b). 25 more xanthones were also synthesized by a modified scheme. Xanthone 2a was identified as the most active inhibitor against both α-glucosidase and aldose reductase (ALR2), with IC50 values of 7.8 ± 0.5 μM and 63.2 ± 0.6 nM, respectively, which was far active than acarbose (35.0 ± 0...
April 2024: Drug Development Research
https://read.qxmd.com/read/38477422/neutrophil-hitchhiking-riding-the-drug-delivery-wave-to-treat-diseases
#13
REVIEW
Menghui Wang, Zhenhua Jin, Haoyu Huang, Xifu Cheng, Qin Zhang, Ying Tang, Xiaoping Zhu, Zhen Zong, Hui Li, Zhikun Ning
Neutrophils are a crucial component of the innate immune system and play a pivotal role in various physiological processes. From a physical perspective, hitchhiking is considered a phenomenon of efficient transportation. The combination of neutrophils and hitchhikers has given rise to effective delivery systems both in vivo and in vitro, thus neutrophils hitchhiking become a novel approach to disease treatment. This article provides an overview of the innovative and feasible application of neutrophils as drug carriers...
April 2024: Drug Development Research
https://read.qxmd.com/read/38459752/protective-effect-of-thymoquinone-nanoemulsion-in-reducing-the-cardiotoxic-effect-of-5-fluorouracil-in-rats
#14
JOURNAL ARTICLE
Bardia Karim, Motahare Arabameri, Fatemeh Alimoradi, Razieh Mansoori, Ali A Moghadamnia, Sohrab Kazemi, Seyed M Hosseini
5-Fluorouracil (5-FU), which is one of the most widely used chemotherapy drugs, has various side effects on the heart. Thymoquinone (TMQ), the main bioactive component of Nigella sativa, has antioxidant and protective effects against toxicity. In this study, we investigated the protective effect of thymoquinone against cardiotoxicity caused by 5-FU in vitro and in vivo models. H9C2 cells were exposed to 5-FU and TMQ, and cell viability was evaluated in their presence. Also, 25 male Wistar rats were divided into five control groups, 5-FU, 2...
April 2024: Drug Development Research
https://read.qxmd.com/read/38450796/hypoxia-expedites-the-progression-of-papillary-thyroid-carcinoma-by-promoting-the-cpt1a-mediated-fatty-acid-oxidative-pathway
#15
JOURNAL ARTICLE
Zhou Liang, Hongsheng He, Bing Zhang, Zhentian Kai, Liang Zong
Hypoxia has been reported to promote the proliferation and migration of thyroid cancer, while the special mechanism was still unclear. HIF-1α/carnitine palmitoyl-transferase 1A (CPT1A) was found to be associated with papillary thyroid carcinoma (PTC) but the biological role of CPT1A in PTC was not explored. The effects of hypoxia and carnitine palmitoyl-transferase 1A (CPT1A) expression on PTC cells were determined by cell counting kit-8 assay, detection of oxidative stress, inflammation response and mitochondrial membrane motential (MMP)...
April 2024: Drug Development Research
https://read.qxmd.com/read/38445811/design-synthesis-in-silico-and-in-vitro-evaluation-of-novel-benzyloxybenzene-substituted-s-%C3%AE-amino-amide-derivatives-as-cholinesterases-and-monoaminoxidases-inhibitor
#16
JOURNAL ARTICLE
Akın Akıncıoğlu
In this study, a series of novel benzyloxybenzene substituted (S)-α-amino acid methyl esters and their amide derivatives were synthesized and evaluated for their inhibitory actions against acetylcholinesterase (AChE), butyrylcholinesterase (BChE), monoamine oxidase A (MAO-A), and monoamine oxidase B (MAO-B). The synthetic strategy was based on starting from benzyl bromide (5) and 4-hydroxybenzaldehyde (6). The reaction of 5 and 6 in the presence of K2 CO3 gave benzyloxybenzaldehyde 7...
April 2024: Drug Development Research
https://read.qxmd.com/read/38444106/deciphering-chemoresistance-in-osteosarcoma-unveiling-regulatory-mechanisms-and-function-through-the-lens-of-noncoding-rna
#17
REVIEW
Hefen Chen, Zhujun Gong, Hong Zhou, Yong Han
Osteosarcoma (OS) is a primary malignant bone tumor and is prevalent in children, adolescents, and elderly individuals. It has the characteristics of high invasion and metastasis. Neoadjuvant chemotherapy combined with surgical resection is the most commonly used treatment for OS. However, the efficacy of OS is considerably diminished by chemotherapy resistance. In recent years, noncoding RNAs (ncRNAs), including microRNAs, long noncoding RNAs, and circular RNAs, are hot topics in the field of chemotherapy resistance research...
April 2024: Drug Development Research
https://read.qxmd.com/read/38424708/berberine-attenuates-inflammation-and-oxidative-stress-and-modulates-lymphocyte-e-ntpdase-in-acute-hyperlipidemia
#18
JOURNAL ARTICLE
Reem S Alruhaimi, Maisa Siddiq Abduh, Ahmad F Ahmeda, Albandari Bin-Ammar, Emadeldin M Kamel, Emad H M Hassanein, Chen Li, Ayman M Mahmoud
Hyperlipidemia is a common clinically encountered health condition worldwide that promotes the development and progression of cardiovascular diseases, including atherosclerosis. Berberine (BBR) is a natural product with acknowledged anti-inflammatory, antioxidant, and metabolic effects. This study evaluated the effect of BBR on lipid alterations, oxidative stress, and inflammatory response in rats with acute hyperlipidemia induced by poloxamer-407 (P-407). Rats were pretreated with BBR (25 and 50 mg/kg) for 14 days and acute hyperlipidemia was induced by a single dose of P-407 (500 mg/kg)...
April 2024: Drug Development Research
https://read.qxmd.com/read/38419305/exploring-new-quinazolin-4-3h-one-derivatives-as-cdk2-inhibitors-design-synthesis-and-anticancer-evaluation
#19
JOURNAL ARTICLE
Basant T Ibrahim, Heba Abdelrasheed Allam, Nehad M El-Dydamony, Marwa A Fouad, Eman R Mohammed
In the present work, five series of new 2,3-disubstituted quinazolin-4(3H)-ones 4a-c, 5a-d, 6a-g, 7a,b, and 9a-c were designed, synthesized, and screened in vitro for their cytotoxic activity against 60 cancer cell lines by the National Cancer Institute, USA. Five candidates 4c, 6a, 6b, 6d, and 6g revealed promising cytotoxicity with significant percentage growth inhibition in the range of 81.98%-96.45% against the central nervous system (CNS) (SNB-19), melanoma (MDA-MB-435), and non-small cell lung cancer (HOP-62) cell lines...
April 2024: Drug Development Research
https://read.qxmd.com/read/38411296/the-current-perspective-and-opportunities-of-small-nucleic-acid-based-therapeutics
#20
REVIEW
Yang Chen, Yang Li, Chao Li, Dandan Zhang, Yuheng Liu, Jingjing Zhang, Shan Guan, Xiaoyan Ding, Qin Xiao
Compared to traditional small molecule and antibody drugs, RNA-based drugs offer a simple design, short research and development cycles, high specificity, broad treatment fields, and long-term efficacy. As a result, RNA-based drugs are extensively used to treat genetic diseases, tumors, viral infections, and other illnesses, suggesting that they have the potential to become the third-largest drug class after small molecule and antibody drugs. Currently, more than 10 small nucleic acid drugs have gained regulatory approval...
April 2024: Drug Development Research
journal
journal
28305
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.